Post-treatment exercise programme improves survival for stage II/III colon cancer

Choosing Wisely: Managing resectable colorectal liver metastases

Optimal management of gastric cancers

Choosing Wisely: ctDNA/ Precision Oncology in colorectal cancers

Temab-A plus bevacizumab shows promising response rates in advanced colorectal cancer

ESMO 2025: Highlights and analysis

ctDNA-guided adjuvant chemo de-escalation reduces toxicity with comparable outcomes in stage III colon cancer

Trastuzumab deruxtecan demonstrates advance in treatment for HER2-positive gastric cancer

Zanzalintinib plus atezolizumab improves survival in refractory mCRC

Domvanalimab, zimberelimab and FOLFOX shows durable survival in advanced HER2-negative GC/GEJC/EAC

Durvalumab combined with FLOT improves survival in resectable gastric and GEJ adenocarcinoma

MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection